How to Buy a Pharmacy: The Complete Playbook

How pharmacy revenue actually works

The headline number in a pharmacy listing is almost always revenue, and revenue is the least useful figure in the file. A store can bill several million dollars a year and keep a very thin slice of it, because the majority of dispensing revenue passes straight through to the drug wholesaler as cost of goods. What you are actually buying is the spread on each prescription plus whatever the store earns outside the pharmacy counter.

That makes three metrics do most of the work. The first is script count — prescriptions filled per day, tracked monthly over several years. It is the closest thing to a unit-volume number and it is much harder to dress up than revenue. The second is gross profit per script, which tells you what the store keeps after drug cost and payer fees; a store with rising revenue and falling gross profit per script is shrinking, not growing. The third is the payer and product mix: government plans, commercial plans, cash customers, and long-term-care or compounding work all pay differently, and a store weighted toward the plans with the worst terms is structurally less profitable no matter how well it is run.

The healthier independents increasingly earn a real share of profit off the dispensing counter entirely — immunizations, point-of-care testing, medication synchronization and adherence packaging, durable medical equipment, compounding, and front-end retail. When you are comparing two stores, the one with more of its profit coming from services it controls the price of is the more durable asset.

What does it cost to buy a pharmacy?

Independent pharmacies are typically priced as a multiple of adjusted earnings — seller's discretionary earnings or EBITDA — plus inventory at cost, which is a large and often underestimated line. Prescription inventory alone can run well into six figures for a single store, and it is real money changing hands at closing even though it is not "goodwill."

Multiples in this category tend to sit in the low-to-mid single digits, and the spread within that range is wide for defensible reasons: payer mix, script trend, lease terms, how much of the profit is service revenue, and whether the departing pharmacist-owner is the reason customers stay. A single-store independent filling a few hundred scripts a day commonly transacts somewhere between the mid six figures and the low seven figures on that math. Value the store yourself before you negotiate — our business valuation guide and calculator walks through add-backs and multiple selection.

One structural note on pricing: a declining-script store is usually cheap for a reason, and the reasons — a competitor's arrival, a retiring prescriber, a lost facility contract, mail-order conversion of a health plan — are rarely reversible by a new owner's enthusiasm. Underwrite the trend, not the peak year.

Financing a pharmacy acquisition

Pharmacy is a well-trodden lending category and several banks maintain dedicated healthcare or pharmacy acquisition teams, which generally makes financing more available here than in less familiar niches.

• SBA 7(a) — the most common path for a single-store purchase, covering goodwill, inventory, equipment, and working capital in one facility. Expect a personal guarantee and an expectation that you will run the store.
• Conventional bank debt — realistic for buyers with existing pharmacy operations or substantial collateral, usually on shorter terms than SBA.
• Seller financing — common and genuinely useful here, because a seller note keeps the departing pharmacist financially invested through the transition, which is exactly the period when patients decide whether to stay.
• Wholesaler and buying-group programs — primary drug wholesalers and independent buying groups often support ownership transitions with financing, transition services, or referral to lenders they work with regularly.

Whatever the structure, budget working capital separately from the purchase price. You will pay the wholesaler on wholesaler terms while waiting on payer remittance, and that timing gap is the most common cash surprise for first-time pharmacy owners. See our SBA acquisition-loan guide and our seller financing guide for how to structure each piece.

What to inspect before you buy

Pharmacy diligence is part financial review and part regulatory review, and the regulatory half is where deals actually fall apart. Start early, because licensing and credentialing timelines are outside your control.

• Monthly script counts for three years — pulled from the dispensing system, not from a summary the broker typed. Look for the trend and for the month a decline started, then find out what happened that month.
• Gross profit per script by payer — the single most informative report in the business. It shows you which contracts are actually profitable and which are being subsidized by the rest of the store.
• PBM contracts and network terms — read them, including the fee and clawback provisions, and confirm whether they survive the transaction or require re-contracting. Ask specifically what happens to reimbursement rates on change of ownership.
• Prescriber and facility concentration — identify the top prescribers and any long-term-care, hospice, or employer contracts. Concentration is not disqualifying, but it must be priced and it should be understood before closing, not after.
• State board licensing and DEA registration — permits do not automatically follow a sale. Confirm the transfer process, the timeline, and the ownership eligibility rules with the state board in writing, and coordinate DEA registration so there is no gap in controlled-substance dispensing.
• Compliance history — board inspection reports, any disciplinary actions, controlled-substance recordkeeping, and audit history with payers. Payer audits with recoupment exposure can follow the business.
• Inventory quality, not just quantity — count it near closing and look at what it is. Slow-moving, short-dated, or discontinued stock is not worth cost, and controlled substances need their own reconciliation.
• The pharmacist-in-charge and staff — if the owner is the PIC and is leaving, you need a named replacement before closing. Technician retention matters more than buyers expect; patients follow the people behind the counter.
• Lease and location — term, assignability, drive-through, parking, and proximity to the prescribers who feed the store. A pharmacy that loses its adjacent clinic loses its business.
• Competitive map — what chains, big-box, grocery, and mail-order options serve the same patients, and whether any local health plan has moved maintenance medications to mail order.

Run these alongside the general business due diligence checklist, and get a healthcare attorney involved earlier than you would in a non-regulated deal.

Pros and cons

Ready to look at listings?

Independent pharmacies appear on the general business-for-sale marketplaces, but a large share of them change hands quietly — through wholesalers, buying groups, pharmacy-specific brokers, and direct approaches to owners nearing retirement. If you are a pharmacist, your professional network is a better sourcing channel than any listing site. If you are not, start by confirming your state allows non-pharmacist ownership before you spend time on deals you cannot legally close.

Related Guides